NOVOCURE LTD shareholders Q3 2023

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Nordwand Advisors, LLC 1,515,000$24,467,2504.85%
Invus Financial Advisors, LLC 350,884$5,666,7773.55%
Deep Track Capital, LP 2,500,000$40,375,0001.56%
TANG CAPITAL MANAGEMENT LLC 492,100$7,947,4151.12%
Palo Alto Investors LP 660,275$10,663,4411.01%
Taylor Frigon Capital Management LLC 91,435$1,476,6750.82%
Soleus Capital Management, L.P. 344,100$5,557,2150.51%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 74,000$1,193,6200.40%
Symmetry Investments LP 92,658$1,4960.31%
SEVEN EIGHT CAPITAL, LP 137,721$2,224,1940.26%
AIGEN INVESTMENT MANAGEMENT, LP 45,433$733,7430.14%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 1,706,588$27,561,3960.14%
TWINBEECH CAPITAL LP 431,913$6,975,3950.13%
Corton Capital Inc. 15,067$243,3320.12%
Quantbot Technologies LP 98,177$1,585,5590.11%
Engineers Gate Manager LP 176,788$2,855,1260.11%
Counterpoint Mutual Funds LLC 7,471$120,6570.10%
Baillie Gifford 6,814,214$110,049,5560.10%
Cubist Systematic Strategies, LLC 800,355$12,925,7330.10%
FOX RUN MANAGEMENT, L.L.C. 19,384$313,0520.09%
External links

This page lists NOVOCURE LTD's shareholders in Q3 2023. To view NOVOCURE LTD's shareholder history, click here.